Exact Mass: 405.266765
Exact Mass Matches: 405.266765
Found 306 metabolites which its exact mass value is equals to given mass value 405.266765,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cassaine
C24H39NO4 (405.28789340000003)
A tricyclic diterpenoid isolated from several plant species of the genus Erythrophleum.
Astromicin
C17H35N5O6 (405.25872100000004)
An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Lisinopril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lisinopril (MK-521) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.
Lisinopril
One of the Angiotensin-converting enzyme inhibitors (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. -- Pubchem; Lisinopril is a drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment of hypertension, congestive heart failure and heart attacks. Historically, lisinopril was the third ACE inhibitor, after captopril and enalapril that was introduced into therapy in early 1990s . Lisinopril has a number of properties that distinguish it from other ACE inhibitors: it is hydrophilic, has long half life and tissue penetration and is not metabolized by the liver. -- Wikipedia; Lisinopril is solely excreted in urine in the unchanged form. Elimination of the drug depends on glomerular filtration and tubular excretion. Rate of lisinopril elimination decreases with old age and kidney or heart failure. There is a relation between creatinine and lisinopril clearance. With prolonged therapy dose reduction can be necessary to avoid accumulation. -- Wikipedia [HMDB] One of the Angiotensin-converting enzyme inhibitors (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. -- Pubchem; Lisinopril is a drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment of hypertension, congestive heart failure and heart attacks. Historically, lisinopril was the third ACE inhibitor, after captopril and enalapril that was introduced into therapy in early 1990s. Lisinopril has a number of properties that distinguish it from other ACE inhibitors: it is hydrophilic, has long half life and tissue penetration and is not metabolized by the liver. -- Wikipedia; Lisinopril is solely excreted in urine in the unchanged form. Elimination of the drug depends on glomerular filtration and tubular excretion. Rate of lisinopril elimination decreases with old age and kidney or heart failure. There is a relation between creatinine and lisinopril clearance. With prolonged therapy dose reduction can be necessary to avoid accumulation. -- Wikipedia.
N-Arachidonoyl Threonine
C24H39NO4 (405.28789340000003)
N-arachidonoyl threonine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Threonine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Threonine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Threonine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Eicosapentaenoyl Cysteine
C23H35NO3S (405.2337520000001)
N-eicosapentaenoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
4-Oxofenretinide
Astromicin
C17H35N5O6 (405.25872100000004)
Cypridina luciferin
Diterpene alkaloid
C24H39NO4 (405.28789340000003)
N-(4-Methoxyphenyl)-all-trans-retinamide
(+/-)-celallocinnine|2-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridecan-4-one|caesalpinine C|celallocinine|Celallocinnin|Celallocinnine
N-[(S)-1-Phenylethyl]-labda-7,12(E),14-triene-17-amide
(+/-)-dihydroperiphylline|4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridecan-2-one|Dihydroperiphyllin|Dihydroperiphylline
(E,E)-Maytenine|Maytenin (1)|maytenine|N1,N8-dicinnamoyl spermidine
(S)-Cypridina luciferin|Cypridina luciferin|[3-(2-sec-butyl-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl)-propyl]-guanidine|{3-[2((S)-sec-Butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidin|{3-[2((S)-sec-butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidine
22alpha,23alpha-epoxy-10-epi-solanida-1,4,9-trien-3-one
C28H39NO_2-Naphthalenol, decahydro-5-(1H-indol-3-ylmethyl)-1,4a-dimethyl-6-methylene-1-(4-methyl-3-penten-1-yl)-, (1S,2S,4aR,5R,8aR)
Ala Lys Ser Thr
Ala Lys Thr Ser
Ala Ser Lys Thr
Ala Ser Thr Lys
Ala Thr Lys Ser
Ala Thr Ser Lys
Gly Lys Thr Thr
Gly Thr Lys Thr
Gly Thr Thr Lys
Lys Ala Ser Thr
Lys Ala Thr Ser
Lys Gly Thr Thr
Lys Ser Ala Thr
Lys Ser Thr Ala
Lys Thr Ala Ser
Lys Thr Gly Thr
Lys Thr Ser Ala
Lys Thr Thr Gly
Ser Ala Lys Thr
Ser Ala Thr Lys
Ser Lys Ala Thr
Ser Lys Thr Ala
Ser Thr Ala Lys
Ser Thr Lys Ala
Thr Ala Lys Ser
Thr Ala Ser Lys
Thr Gly Lys Thr
Thr Gly Thr Lys
Thr Lys Ala Ser
Thr Lys Gly Thr
Thr Lys Ser Ala
Thr Lys Thr Gly
Thr Ser Ala Lys
Thr Ser Lys Ala
Thr Thr Gly Lys
Thr Thr Lys Gly
NAG-3H-ABA
C24H39NO4 (405.28789340000003)
12-HETE-GABA
C24H39NO4 (405.28789340000003)
15-HETE-GABA
C24H39NO4 (405.28789340000003)
12-oxo-PDA-Ile
C24H39NO4 (405.28789340000003)
NA 24:5;O3
C24H39NO4 (405.28789340000003)
1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butane-1,4-diol
1-[4-(1-ADAMANTYL)PHENOXY]-3-PIPERIDINOPROPAN-2-OL HYDROCHLORIDE
C24H36ClNO2 (405.24344260000004)
Urea, N-cyclohexyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-pyridinylmethyl)- (9CI)
Methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate
4-Oxofenretinide
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
2(S)-ACETYLTHIO-BENZENEPROPANOIC ACID N-CYCLOHEXYLCYCLOHEXANAMINE
C23H35NO3S (405.2337520000001)
(S)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PROPANOATE
Bencyclane fumarate
C23H35NO5 (405.25151000000005)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
4-(N-Ethyl-N-benzyl)amino benzoaldehyde-1,1-diphenylhydrazone
2(r)-acetylthio-benzenepropanoic acid n-cyclohexylcyclohexanamine
C23H35NO3S (405.2337520000001)
8-Cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
Carbamic acid, N-[(1S)-1-[[[(1S)-1-(hydroxymethyl)-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester
N-(4-Methoxyphenyl)-all-trans-retinamide
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Celacinnine
A spermidine alkaloid that is isolated from Maytenus heterophylla and Maytenus senegalensis.
3-Hydroxy-4-(icosa-5,8,11,14-tetraenoylamino)butanoic acid
C24H39NO4 (405.28789340000003)
2-[trans-(4-Aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurine
N-(1-Isopropylpiperidin-4-YL)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
C21H35N5O3 (405.27397600000006)
3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
7alpha,12alpha-Dihydroxy-3-oxo-5beta-cholan-24-Oate
A bile acid anion that is the conjugate base of 7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
1-[4-(9-Benzylfluoren-9-yl)but-2-ynyl]azepane
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
N-[[4-(diethylamino)phenyl]methyl]-1-[2-(1-piperidinyl)ethyl]-2-benzimidazolamine
22alpha,23alpha-Epoxy-solanida-1,4,9-trien-3-one
A natural product found in Solanum campaniforme.
2-[[4-amino-6-(2-methylanilino)-1,3,5-triazin-2-yl]methyl-methylamino]-N-(2-ethylphenyl)acetamide
4-[4-[(1-Cyclopentyl-5-tetrazolyl)-pyridin-4-ylmethyl]-1-piperazinyl]phenol
N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cyclohexanecarboxamide
4-[[3-(Diethylamino)propylamino]methylidene]-2-(2,6-dimethylphenyl)isoquinoline-1,3-dione
1-[(2S,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-[(2S,3R,6S)-6-[2-[4-(3-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)oxan-3-yl]-3-(3-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)oxan-3-yl]-3-(3-methoxyphenyl)urea
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
1-[(2S,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3R,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-(2-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
[(8S,9R,10S)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
1-[(2R,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea
1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-(2-fluorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2R,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(2S,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea
C20H28FN5O3 (405.21760700000004)
1-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
1-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone
[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
(E)-2-(decanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid
C20H39NO5S (405.25488040000005)
SPHP(21:1)
C21H44NO4P (405.30077940000007)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
SPHP(20:2)
C20H40NO5P (405.2643960000001)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C24H39NO4 (405.28789340000003)
(2e)-1-[(6s)-8-hydroxy-6-phenyl-1,5,9-triazacyclotridec-8-en-1-yl]-3-phenylprop-2-en-1-one
(1s,2s,4ar,5s,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
1-(2-hydroxypropyl)-2-methyl-6-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]-9h-carbazole-3,4-dione
11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one
C23H35NO5 (405.25151000000005)
(2z)-1-(6-hydroxy-8-phenyl-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one
methyl (1'r,3r,5's,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate
C23H35NO5 (405.25151000000005)
(4s,6s,8s,10s,11e,13e,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
(2z)-1-[(8r)-6-hydroxy-8-phenyl-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one
(2e,5z,8s,10s,12s,14s)-8,10,12,14-tetramethoxy-2,5-dimethyl-7-methylideneheptadeca-2,5,16-trienenitrile
C24H39NO4 (405.28789340000003)
(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol
7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol
(1s,2s,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(1s,4r,4as,7r,7as,11as)-8-(1h-indol-3-yl)-9-isopropyl-4,4a,7-trimethyl-1h,2h,3h,4h,5h,6h,7h,7ah,10h,11h-cyclohexa[e]naphthalen-1-ol
(2r,3r,4s,7r,8s,11r,12r,15s)-4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol
(1s,2s,4as,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
11-ethyl-9-hydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one
C23H35NO5 (405.25151000000005)
1-[(2r)-2-hydroxypropyl]-2-methyl-6-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]-9h-carbazole-3,4-dione
(1s,2r,3s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one
C23H35NO5 (405.25151000000005)
(1r,4as,4br,7r,8s,8ar,10as)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
(1r,2s,3r,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one
C23H35NO5 (405.25151000000005)
2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide
C17H35N5O6 (405.25872100000004)
5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
methyl (1'r,3r,5'r,6s,9's,11'r,12'r)-6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate
C23H35NO5 (405.25151000000005)
(1s,2s,4ar,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
(2s,5s,6r,9s,11r,14r,15s)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
(1s,4r,8r)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid
C23H35NO5 (405.25151000000005)
4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol
8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
(1s,2s,3r,5r,7s,10r,11s,12r,13r,14s,16r,17r,18s,19s)-4-ethyl-12,16-dimethoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-14,18-diol
C23H35NO5 (405.25151000000005)
8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotridec-8-en-1-yl)-3-phenylprop-2-en-1-one
(1s,4r,4as,7r,7as,8s,9r,11as)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
(1r,4s,4ar,7s,7ar,8r,9s,11ar)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
(1s,2r,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(3r,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid
C23H35NO5 (405.25151000000005)
(1r,4ar,4br,7r,8s,8as,10ar)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-hexyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid
C23H35NO5 (405.25151000000005)
1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol
n-(6-hydroxy-1,6-dimethyl-4-{2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl}-5-(methylideneamino)-octahydronaphthalen-1-yl)carboximidic acid
methyl 6-ethyl-6,9'-dihydroxy-3'-methyl-3'-azaspiro[oxane-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate
C23H35NO5 (405.25151000000005)
11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one
C23H35NO5 (405.25151000000005)
(2e)-1-[(8s)-6-hydroxy-8-phenyl-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one
(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol
(1s,2s,4ar,5s,8ar)-5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(1s,2s,3r,6r,7r,10s,11s,12s)-2-(2h-1,3-benzodioxol-5-ylmethyl)-n-(2-methylpropyl)tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboximidic acid
(3s,7e,11e)-14-[1-(carboxymethyl)-2-oxo-5h-pyrrol-3-yl]-3,7,11-trimethyltetradeca-7,11-dienoic acid
C23H35NO5 (405.25151000000005)
n-[3-({4-[(1-hydroxy-3-phenylprop-2-en-1-ylidene)amino]butyl}amino)propyl]-3-phenylprop-2-enimidic acid
n-{2-[(2s,5r)-5-[(1s,4s,4as,7r,8r,8as)-7-hydroxy-4,7-dimethyl-4,8-bis(methylideneamino)-octahydronaphthalen-1-yl]-5-methyloxolan-2-yl]propan-2-yl}carboximidic acid
5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(4s,6s,8s,10s,11e,13e,15z)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
(1s,4r,4as,8r,8as)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
2-{1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl}propan-2-ol
(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyheptadeca-4,6,9-trienimidic acid
C24H39NO4 (405.28789340000003)
5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol
(4br,10as)-4b,7,7,10a-tetramethyl-2-(2-sulfonatoethyl)-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium
C23H35NO3S (405.2337520000001)
n-[(1s,4s,4as,5r,6r,8as)-6-hydroxy-1,6-dimethyl-4-[(2r,5s)-2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl]-5-(methylideneamino)-octahydronaphthalen-1-yl]carboximidic acid
2-(dimethylamino)ethyl 2-[(1r,2e,4ar,4br,7s,8ar,10as)-7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-decahydrophenanthren-2-ylidene]acetate
C24H39NO4 (405.28789340000003)
(2r,5r,6s,9r,11s,14s,15r)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyheptadeca-4,6,9-trienimidic acid
C24H39NO4 (405.28789340000003)
(2e)-1-(6-hydroxy-8-phenyl-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one
2-[(1s,2s,5s,7s,11r,14s)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl]propan-2-ol
(1s,2r,3s,5r,6s,8s,9s,10r,13s,16r,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one
C23H35NO5 (405.25151000000005)
8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol
(4s,6s,8s,10s,11e,13z,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C24H39NO4 (405.28789340000003)